Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Freeze-dried Nasal Spray Live Attenuated Influenza Vaccine in Ages 3-17
NCT06280144Phase 4Recruiting
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Sep 2023
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BCHT LAIV in influenza, sponsored by Changchun BCHT Biotechnology Co.. Started Sep 2023; status: recruiting.
02
Drugs
BCHT LAIV
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06280144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06280144.